Influenza

Drug Reduces Length and Severity of Types A and B Flu

Published in TB and Outbreaks Week, March 7th, 2000

Oseltamivir, taken orally, reduces the duration and severity of flu in healthy adults, according to an article in the February 23, 2000, issue of The Journal of the American Medical Association.

John J. Treanor, MD, from the University of Rochester, New York, and colleagues conducted a U.S.-wide study (60 centers) where 629 healthy adults aged 18 to 65 who presented within 36 hours of onset of flu symptoms and who had documented oral temperatures of 100.4(degree)F or higher plus one or more respiratory symptoms (cough, sore throat, or nasal symptoms) and one or more other symptoms (headache, malaise, myalgia, sweats and/or chills, or fatigue) were enrolled. ...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2000-03-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry